ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹-537 Cr | ₹-158 Cr | ₹-230 Cr | ₹321 Cr | ₹428 Cr |
What is the latest Net Current Assets ratio of ERIS LIFESCIENCES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹-537 Cr |
| Mar2025 | ₹-158 Cr |
| Mar2024 | ₹-230 Cr |
| Mar2023 | ₹321 Cr |
| Mar2022 | ₹428 Cr |
How is Net Current Assets of ERIS LIFESCIENCES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹-537 Cr | Negative | |
| Mar2025 | ₹-158 Cr | Negative | |
| Mar2024 | ₹-230 Cr | Negative | |
| Mar2023 | ₹321 Cr | -24.83 | |
| Mar2022 | ₹428 Cr | - | |
Compare Net Current Assets of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹15,750.1 Cr | -1.2% | -14.1% | -29.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -0.2% | -4.9% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,904.0 Cr | 1.3% | -2.3% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹172,213.0 Cr | -1.5% | -5.8% | 29.3% | Stock Analytics | |
| CIPLA | ₹106,138.0 Cr | 0.1% | -4.2% | -14.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,304.0 Cr | 1.9% | 5.7% | 0.4% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | -1.2% |
-14.1% |
-29.6% |
| SENSEX | 0.9% |
-0.8% |
-10.5% |
You may also like the below Video Courses